Mkts

Cue Biopharma, Inc.

NASDAQ: CUE
$7.43-6.67 (-47.30%)
As of Nov 17, 11:29 AM ET

Key statistics

Day range
7.1313.53
52-week range
4.9745.50
Today
Open13.40
Previous close7.43
Volume21.4K
Valuation
Market cap101.96M
P/E ratio—
EPS (TTM)-26.99
Income & risk
Dividend / yield—
Beta2.92
Avg volume238.2K
Discussion

CUE News

Stories mentioning CUE from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue5,68621,9422,1492,954421.001,5763,3362,658
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development6,89716,5324,7547,9108,5477,1859,3819,530
Sales General & Admin
Total Operating Expenses11,03919,9659,74411,58912,72011,21012,15113,041
Operating Income (Loss)(5,353)1,977(7,595)(8,635)(12,299)(9,634)(8,815)(10,383)
Interest Income
Interest Expense100.00
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(5,178)1,585(7,448)(8,482)(12,257)(9,496)(8,660)(10,171)
Earnings Per Share (Basic)(1.08)0.02(0.07)(0.09)(4.95)(0.17)(0.17)(0.20)
Earnings Per Share (Diluted)(1.08)0.02(0.07)(0.09)(4.95)(0.17)(0.17)(0.20)
Weighted Average Shares Outstanding (Basic)4,80794,732100,86995,4592,47556,32851,23050,175
Weighted Average Shares Outstanding (Diluted)4,80794,732100,86995,4592,47556,32851,23050,175

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CUE

Cue Biopharma, Inc. (NASDAQ: CUE) is a stock listed on the Nasdaq Stock Market under the ticker symbol CUE. It last traded at $7.43 (Nov 17, 2026, 11:29 AM ET), down 47.3% on the day. That gives Cue Biopharma a market capitalisation of $102.0M.

Over the past 52 weeks CUE has traded between $4.97 and $45.50.

Revenue for the quarter ended Mar 31, 2026 was $5.7M; a net loss of $5.2M. Revenue was up 1251% from $421.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$5.7M-$5.2M-91.1%
Dec 31, 2025$21.9M$1.6M7.2%
Sep 30, 2025$2.1M-$7.4M-346.6%
Jun 30, 2025$3.0M-$8.5M-287.1%

From Cue Biopharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…